Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies

Cancer-associated thrombosis (CAT) is a leading cause of death in cancer patients receiving outpatient chemotherapy. The latest guidelines emphasize stratifying the patients in terms of CAT risks periodically. Multiple risk assessment models (RAMs) were developed to classify patients and guide th...

全面介绍

Saved in:
书目详细资料
Main Authors: Mosaad, Manar, Elnaem, Mohamed Hassan Abdelaziz, Cheema, Ejaz, Ibrahim, Ismail, Ab Rahman, Jamalludin, Kori, Ahlam Naila, How, Soon Hin
格式: Article
语言:English
English
出版: Dove Medical Press Ltd 2021
主题:
在线阅读:http://irep.iium.edu.my/91290/7/91290_Cancer-Associated%20Thrombosis_Scopus.pdf
http://irep.iium.edu.my/91290/13/91290_Cancer-Associated%20Thrombosis.pdf
http://irep.iium.edu.my/91290/
标签: 添加标签
没有标签, 成为第一个标记此记录!
id my.iium.irep.91290
record_format dspace
spelling my.iium.irep.912902022-07-15T02:13:29Z http://irep.iium.edu.my/91290/ Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies Mosaad, Manar Elnaem, Mohamed Hassan Abdelaziz Cheema, Ejaz Ibrahim, Ismail Ab Rahman, Jamalludin Kori, Ahlam Naila How, Soon Hin R Medicine (General) RC0254 Neoplasms. Tumors. Oncology (including Cancer) RS Pharmacy and materia medica Cancer-associated thrombosis (CAT) is a leading cause of death in cancer patients receiving outpatient chemotherapy. The latest guidelines emphasize stratifying the patients in terms of CAT risks periodically. Multiple risk assessment models (RAMs) were developed to classify patients and guide thromboprophylaxis to high-risk patients. This study aimed to discuss and highlight different RAMs across various malignancy types with their related advantages and disadvantages. A scoping review was conducted using predefined search terms in three scientific databases, including Google Scholar, Science Direct, and PubMed. The search for studies was restricted to original research articles that reported risk assessment models published in the last thirteen years (between 2008 and 2021) to cover the most recently published evidence following the development of the principal risk assessment score in 2008. Data charting of the relevant trials, scores, advantages, and disadvantages were done iteratively considering the malignancy type. Of the initially identified 1115 studies, 39 studies with over 67,680 patients were included in the review. In solid organ malignancy, nine risk assessment scores were generated. The first and most known Khorana risk score still offers the best available risk assessment model when used for high-risk populations with a threshold of 2 and above. However, KRS has a limitation of failure to stratify low-risk patients. The COMPASS-CAT score showed the best performance in the lung carcinoma patients who have a higher prevalence of thrombosis than other malignancy subtypes. In testicular germ cell tumours, Bezan et al RAM is a validated good discriminatory RAM for this malignancy subtype. CAT in haematological malignancy seems to be under-investigated and has multiple disease-related, and treatment-related confounding factors. AL-Ani et al score performed efficiently in acute leukemia. In multiple myeloma, both SAVED and IMPEDED VTE scores showed good performance. Despite the availability of different disease-specific scores in lymphoma-related thrombosis, the standard of care needs to be redefined. Dove Medical Press Ltd 2021 Article PeerReviewed application/pdf en http://irep.iium.edu.my/91290/7/91290_Cancer-Associated%20Thrombosis_Scopus.pdf application/pdf en http://irep.iium.edu.my/91290/13/91290_Cancer-Associated%20Thrombosis.pdf Mosaad, Manar and Elnaem, Mohamed Hassan Abdelaziz and Cheema, Ejaz and Ibrahim, Ismail and Ab Rahman, Jamalludin and Kori, Ahlam Naila and How, Soon Hin (2021) Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies. International Journal of General Medicine, 14. pp. 3881-3897. ISSN 1178-7074 10.2147/IJGM.S320492
institution Universiti Islam Antarabangsa Malaysia
building IIUM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
url_provider http://irep.iium.edu.my/
language English
English
topic R Medicine (General)
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
RS Pharmacy and materia medica
spellingShingle R Medicine (General)
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
RS Pharmacy and materia medica
Mosaad, Manar
Elnaem, Mohamed Hassan Abdelaziz
Cheema, Ejaz
Ibrahim, Ismail
Ab Rahman, Jamalludin
Kori, Ahlam Naila
How, Soon Hin
Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
description Cancer-associated thrombosis (CAT) is a leading cause of death in cancer patients receiving outpatient chemotherapy. The latest guidelines emphasize stratifying the patients in terms of CAT risks periodically. Multiple risk assessment models (RAMs) were developed to classify patients and guide thromboprophylaxis to high-risk patients. This study aimed to discuss and highlight different RAMs across various malignancy types with their related advantages and disadvantages. A scoping review was conducted using predefined search terms in three scientific databases, including Google Scholar, Science Direct, and PubMed. The search for studies was restricted to original research articles that reported risk assessment models published in the last thirteen years (between 2008 and 2021) to cover the most recently published evidence following the development of the principal risk assessment score in 2008. Data charting of the relevant trials, scores, advantages, and disadvantages were done iteratively considering the malignancy type. Of the initially identified 1115 studies, 39 studies with over 67,680 patients were included in the review. In solid organ malignancy, nine risk assessment scores were generated. The first and most known Khorana risk score still offers the best available risk assessment model when used for high-risk populations with a threshold of 2 and above. However, KRS has a limitation of failure to stratify low-risk patients. The COMPASS-CAT score showed the best performance in the lung carcinoma patients who have a higher prevalence of thrombosis than other malignancy subtypes. In testicular germ cell tumours, Bezan et al RAM is a validated good discriminatory RAM for this malignancy subtype. CAT in haematological malignancy seems to be under-investigated and has multiple disease-related, and treatment-related confounding factors. AL-Ani et al score performed efficiently in acute leukemia. In multiple myeloma, both SAVED and IMPEDED VTE scores showed good performance. Despite the availability of different disease-specific scores in lymphoma-related thrombosis, the standard of care needs to be redefined.
format Article
author Mosaad, Manar
Elnaem, Mohamed Hassan Abdelaziz
Cheema, Ejaz
Ibrahim, Ismail
Ab Rahman, Jamalludin
Kori, Ahlam Naila
How, Soon Hin
author_facet Mosaad, Manar
Elnaem, Mohamed Hassan Abdelaziz
Cheema, Ejaz
Ibrahim, Ismail
Ab Rahman, Jamalludin
Kori, Ahlam Naila
How, Soon Hin
author_sort Mosaad, Manar
title Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
title_short Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
title_full Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
title_fullStr Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
title_full_unstemmed Cancer-Associated Thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
title_sort cancer-associated thrombosis: a clinical scoping review of the risk assessment models across solid tumours and haematological malignancies
publisher Dove Medical Press Ltd
publishDate 2021
url http://irep.iium.edu.my/91290/7/91290_Cancer-Associated%20Thrombosis_Scopus.pdf
http://irep.iium.edu.my/91290/13/91290_Cancer-Associated%20Thrombosis.pdf
http://irep.iium.edu.my/91290/
_version_ 1738510110759583744
score 13.250246